Dissociation of renal TGF-β and hypertrophy in female rats with diabetes mellitus

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Lane, Pascale H ^a,b   Sun, Jianhong ^a   Devish, Kay ^a   Langer, William J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Estrogen; Ovarectomy; Transforming growth factor inducible gene H3

Indexed keywords

ESTRADIOL; ESTROGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ESTRADIOL BLOOD LEVEL; EXTRACELLULAR MATRIX; FEMALE; GENE; KIDNEY HYPERTROPHY; KIDNEY MASS; MATURITY ONSET DIABETES MELLITUS; NEWBORN; NONHUMAN; ONSET AGE; OVARIECTOMY; PREPUBERTAL ONSET DIABETES MELLITUS; PREPUBERTY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE GENE H3;

EID: 6344233669     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00031.2004     Document Type: Article

References (57)

1. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, and Tamborlane WV. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315: 215-219, 1986.
2. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, and Sereni F. Epidemiology of chronic renal failure in children: data from the ItalKid Project. Pediatrics 111: e382-e387, 2003.
3. Bach L, Cooper M, Vranes D, Allen T, Rumble J, and Jerums G. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat. Diabetes Res 27: 27-38, 1994.
4. Bach L, Cox A, and Jerums G. Diabetes-related renal growth and IGF-I accumulation in castrated rats. Diabetes Res Clin Pract 14: 15-20, 1991.
5. Bach LA and Jerums G. Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 39: 557-562, 1990.
6. Bloch CA, demons P, and Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 110: 481-487, 1987.
7. Border WA and Noble NA. Evidence that TGF-β should be a therapeutic target in diabetic nephropathy. Kidney Int 54: 1390-1391, 1998.
8. Breyer J, Bain RP, Evans J, Nahman N, Lewis EJ, Cooper M, McGill J, and Berl T. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy: The Collaborative Study Group. Kidney Int 50: 1651-1658, 1996.
9. Chen S, Jim B, and Ziyadeh FN. Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23: 532-543, 2003.
10. Christian JL and Nakayama T. Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-β family signals. BioEssays 21: 382-390, 1999.
11. Cook JS, Hoffman RP, Stene MA, and Hansen JR. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 77: 725-730, 1993.
12. Coonrod B, Ellis D, Becker D, Bunker C, Kelsey S, Lloyd C, Drash A, Kuller L, and Orchard TJ. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 16: 1376-1383, 1993.
13. Dubey RK, Gillespie DG, Keller PJ, Imthurn B, Zacharia LC, and Jackson EK. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells. Hypertension 39: 418-424, 2002.
14. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43: 1205-1223, 2000.
15. Gibson MA, Kumaratilake JS, and Cleary EG. Immunohistochemical and ultrastructural localization of MP78/70 (βig-h3) in extracellular matrix of developing and mature bovine tissues. J Histochem Cytochem 45: 1683-1696, 1997.
16. Gilbert RE, Wilkinson-Berka JL, Johnson DW, Cox A, Soulis T, Wu LL, Kelly DJ, Jerums G, Pollock CA, and Cooper ME. Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats. Kidney Int 54: 1052-1062, 1998.
17. Goran MI and Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 50: 2444-2450, 2001.
18. Griffin ML, South S, Yankov VI, Booth RA, Asplin CM, Veldhuis JD, and Evans WS. Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann Med 26: 331-340, 1994.
19. Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill D, Thomas C, Sheppard M, and Logan A. The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 141: 1196-1208, 2000.
20. Ishikawa I, Maeda K, Nakai S, and Kawaguchi Y. Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 35: 1072-1075, 2000.
21. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, and Parving HH. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int 56, Suppl 71: S101-S105, 1999.
22. Jerums G, Panagiotopoulos S, Forbes J, Osicka T, and Cooper ME. Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys 419: 55-62, 2003.
23. Kalender B, Ozturk M, Tuncdemir M, Uysal O, Dagistanli F, and Yegenag Erek E. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta HIstochem 104: 123-130, 2002.
24. Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, and Gilbert RE. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 61: 31-39, 2002.
25. Kelly DJ, Zhang Y, Hepper C, Gow RM, Jaworski K, Kemp BE, Wilkinson-Berka JL, and Gilbert RE. Protein kinase C-β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 52: 512-518, 2003.
26. Knorr D, Vanha-Perttula T, and Lipsett M; Structure and function of rat testis through pubescence. Endocrinology 86: 1298-1304, 1970.
27. Lane P. Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol 283: F589-F600, 2002.
28. 1 in experimental diabetes. Pediatr Nephrol 16: 1033-1039, 2001.
29. Lane PH. Age of onset of streptozocin diabetes determines the renal structural response in the rat. Pediatr Res 41: 912-915, 1997.
30. Lane PH. Determination of mean glomerular volume in nephrectomy specimens. Lab Invest 72: 765-770, 1995.
31. Lane PH, Steffes MW, and Mauer SM. Estimation of glomerular volume: a comparison of four methods. Kidney Int 41: 1085-1089, 1992.
32. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J, and Purchio A. βIG-H3, a novel secretory protein inducible by transforming growth factor-β, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 104: 844-849, 1995.
33. Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper ME, Truong LD, Johnson RJ, and Lan HY. Advanced glycation end products activate Smad signaling via TGF-β-dependent and -independent mechanisms: implications for diabetic renal and vascular disease. FASEB J 18: 176-178, 2004.
34. Mangili RR, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi G, and the Italian Microalbuminuria Study Group. Arterial hypertension and microalbuminuria in IDDM: The Italian Microalbuminuria Study. Diabetologia 37: 1015-1024, 1994.
35. Matsuda T, Yamamoto T, Muraguchi A, and Saatcioglu F. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J Biol Chem 276: 42908-42914, 2001.
36. Mauer SM, Drummond K, and Group IDNS. The early natural history of nephropathy in type 1 diabetes. I. Study design and baseline characteristics of the study participants. Diabetes 51: 1572-1579, 2002.
37. Melhem MF, Craven PA, Liachenko J, and Derubertis FR. α-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13: 108-116, 2002.
38. Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R, and Sinaiko AR. Insulin resistance during puberty. Results from clamp studies in 357 children. Diabetes 48: 2039-2044, 1999.
39. Ohno S, Noshiro M, Makihira S, Kawamoto T, Shen M, Yan W, Kawashima-Ohya Y, Fujimoto K, Tanne K, and Kato Y. RGD-CAP (βig-h3) enhances the spreading of chondrocytes and fibroblasts via integrin αβ Biochim Biophys Acta 1451: 196-205, 1999.
40. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, and Kuller LH. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124, 1990.
41. Piek E, Heldin CH, and Ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13: 2105-2124, 1999.
42. Potau N, Ibanez L, Tique S, and Carrascosa A. Pubertal changes in insulin secretion and peripheral insulin sensitivity. Horm Res 48: 219-226, 1997.
43. Qin J, Zhang Z, Liu J, Sun L, Hu L, Cooper ME, and Cao Z. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes. Kidney Int 64: 565-571, 2003.
44. Ravid M, Brosh D, Ravid-Safran D, Levy Z, and Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158: 998-1004, 1998.
45. Ruggenenti P, Gambara V, Perna A, Bertani T, and Remuzzi G. The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol 9: 2336-2343, 1998.
46. Savage S, Nagel N, Estacio R, Lukken N, and Schrier R. Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25: 836-844, 1995.
47. Schnaper HW, Poncelet AC, and Hayashida T. Talking at cross pureposes: molecular interactions downstream from TGF-β. Kidney Int 60: 2415-2416, 2001.
48. Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, Friess H, and Buchler MW. Induction and expression of βig-h3 in pancreatic cancer cells. Biochim Biophys Acta 1588: 1-6, 2002.
49. Seliger SL, David C, and Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10: 219-225, 2001.
50. Sharma K, Jin Y, Guo J, and Ziyadeh FN. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996.
51. Silbiger SR and Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25: 515-533, 1995.
52. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, and Purchio A. cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 11: 511-522, 1992.
53. Volpini R, da Silva C, Costa R, and Coimbra T. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Diabetes Metab Res Rev 19: 43-51, 2003.
54. Wallen WJ, Belanger MP, and Wittnich C. Body weight and food intake profiles are modulated by sex hormones and tamoxifen in chronically hypertensive rate. J Nutr 132: 2246-2250, 2002.
55. Wallen WJ, Belanger MP, and Wittnich C. Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. J Nutr 131: 2351-2357, 2001.
56. Xiao S, Gillespie DG, Baylis C, Jackson EK, and Dubey RK. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension 3: 645-650, 2001.
57. 1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int 60: 2097-2108, 2001.